임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 1상모집 예정· Systemic Lupus ErythematosusStudy to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV)
리드: 아스트라제네카
- 1상모집 예정· Healthy ParticipantsA Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers
리드: 아스트라제네카
- 1상모집 중· Staphylococcus Aureus Bloodstream InfectionA Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Healthy ParticipantsA Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants
리드: 아스트라제네카
- 1상모집 중· Healthy ParticipantsA Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults
리드: 아스트라제네카
- 1상모집 중· Hepatic ImpairmentA Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
리드: 아스트라제네카
- 1상모집 중· Healthy ParticipantsA Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
리드: 아스트라제네카
- 1상모집 중· EGFR Mutation-positive NSCLCPhase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC
리드: 아스트라제네카
- 1상모집 중· Fallopian Tube CancerDrug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
리드: 아스트라제네카
- 1상모집 중· Moderate Hepatic ImpairmentA Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Healthy ParticipantsA Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Healthy Japanese Participants
리드: 아스트라제네카
- 1상모집 중· Healthy ParticipantsA Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants
리드: 아스트라제네카
- 1상모집 중· Multiple SclerosisAn Open-label Study of AZD0120 in Adults With Multiple Sclerosis
리드: 아스트라제네카
- 1상모집 중· Rheumatoid ArthritisStudy Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
리드: 아스트라제네카
- 1상모집 중· Healthy ParticipantsA Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
리드: 아스트라제네카
- 1상모집 중· Autosomal Dominant Polycystic Kidney DiseaseSafety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
리드: 아스트라제네카
- 1상모집 중· Haematologic NeoplasmsA Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
리드: 아스트라제네카
- 1상모집 중· Recurrent or Metastatic Solid TumorsA Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
협력: 아스트라제네카
- 1상모집 중· Chronic Kidney DiseaseA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
리드: 아스트라제네카
- 1상모집 중· Biliary Tract CancersTargeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
협력: 아스트라제네카
- 1상모집 중· Locally Advanced or Metastatic Solid TumorAZD5305 hADME in Patients With Advanced Solid Malignancies
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Advanced Solid MalignanciesModular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
리드: 아스트라제네카
- 1상모집 중· Metastatic Castration-Resistant Prostate CancerA Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
리드: 아스트라제네카
- 1상모집 예정· NeoplasmHuman ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Advanced Solid TumorA Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
리드: 아스트라제네카
- 1상모집 중· Non-small Cell Lung CancerPhase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· CardiovascularA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Soft Tissue SarcomaStudy Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma
협력: 아스트라제네카
- 1상모집 중· Non-small Cell Lung CancerA Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
리드: 아스트라제네카
- 1상모집 중· Advanced Solid TumorA Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Solid TumorA Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
협력: 아스트라제네카
- 1상모집 중· Resectable Hepatocellular CarcinomaSIRT With Tremelimumab and Durvalumab for Resectable HCC
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Esophageal CancerOrgan-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer
협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Advanced Solid TumoursA Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Neurofibromatosis Type 1Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas
리드: 아스트라제네카 · 협력: 머크(MSD)
- 1상모집 중단 (진행 중)· Non-Small Cell Lung Cancer (NSCLC)HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
협력: 아스트라제네카, 머크(MSD)
- 1상모집 중단 (진행 중)· Primary Central Nervous System LymphomaAcalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
협력: 아스트라제네카
- 1상모집 중· Locally Advanced or Metastatic Non-Small Cell Lung CancerPhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· B-cell Non Hodgkin LymphomaA Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Advanced or Metastatic NSCLCPhase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Metastatic Breast CancerA Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
리드: 아스트라제네카
- 1상모집 중단 (진행 중)· Neurofibromatosis 1A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
리드: 아스트라제네카 · 협력: 머크(MSD)
- 1상모집 중단 (진행 중)· Breast CancerDS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
협력: 아스트라제네카, 머크(MSD)
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.